Effects of prenatal and postnatal exposure to amitraz on norepinephrine, serotonin and dopamine levels in brain regions of male and female rats

Toxicology

Volumn 287, Issue 1-3, 2011, Pages 145-152

  Del Pino, J ^a   Martinez M A ^a   Castellano, V J ^a   Ramos, E ^a   Martinez Larranaga M R ^a   Anadon A ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Amitraz; Biogenic amines; Developmental neurotoxicology; Male and female offspring rats; Prenatal and postnatal pesticide exposure

Indexed keywords

DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYPOTHALAMUS; MALE; NONHUMAN; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; RAT; SEX TRANSFORMATION;

ANIMALS; BRAIN; DOPAMINE; FEMALE; FETUS; INSECTICIDES; MALE; MATERNAL EXPOSURE; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; RATS; RATS, WISTAR; SEROTONIN; TOLUIDINES;

RATTUS;

EID: 79960700103     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.06.009     Document Type: Article

References (100)

1. Aldridge J.E., Seidler F.J., Meyer A., Thillai I., Slotkin T.A. Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods. Environ. Health Perspect. 2003, 111(14):1736-1743.
2. Aldridge J.E., Seidler F.J., Slotkin T.A. Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect. 2004, 112(2):148-155.
3. Aldridge J.E., Meyer A., Seidler F.J., Slotkin T.A. Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure. Environ. Health Perspect. 2005, 113(8):1027-1031.
4. Altobelli D., Martire M., Maurizi S., Preziosi P. Interaction of formamidine pesticides with the presynaptic α2-adrenoceptor regulating [H3] noradrenaline release from rat hypothalamic synaptosomes. Toxicol. Appl. Pharmacol. 2001, 172:179-185.
5. Ansorge M.S., Morelli E., Gingrich J.A. Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviours in mice. J. Neurosci. 2008, 28(1):199-207.
6. Artigas F., Sarrias M.J., Adell A., Gelpi E. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sci. 1986, 39(17):1571-1578.
7. Aziz S.A., Knowles C.O. Inhibition of monoamine oxidase by the pesticide chlordimeform and related compounds. Nature 1973, 242:417-418.
8. Bandyopadhyay S., Hablitz J.J. Dopaminergic modulation of local network activity in rat prefrontal cortex. J. Neurophysiol. 2007, 97(6):4120-4128.
9. Barone S., Das K.P., Lassiter T.L., White L.D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 2000, 21(1-2):15-36.
10. Beeman R.W., Matsumura F. Chlordimeform: a pesticide acting upon amine regulatory mechanisms. Nature 1973, 242(5395):273-274.
11. Benezet H.J., Chang K.M., Knowles C.O. Formamidin pesticides-metabolic aspects of neurotoxicity. Pesticide and Venom Neurotoxicity 1978, 189-206. Plenum Press, New York. D.C. Shankland, R.M. Hollingworth, T. Smith (Eds.).
12. Bernardi M.M., Palermo-Neto J. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment. Gen. Pharmacol. 1983, 14:545-547.
13. Bernardi M.M., Palermo-Neto J., De Souza H. Effects of a single and long-term haloperidol treatment on open field behaviour of rats. Psychopharmacology 1981, 73:171-175.
14. Berry M.D., Juorio A.V., Paterson I.A. Possible mechanisms of action of (-) deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog. Neurobiol. 1994, 44(2):141-161.
15. Bloom A.S., Staaz C.G., Dieringer T. Pyrethroid effects on operant responding and feeding. Neurobehav. Toxicol. Teratol. 1983, 5:321-324.
16. Burgess N., Maguire E.A., O'keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002, 35(4):625-641.
17. Buznikov G.A., Shmukler Y.B., Lauder J.M. From oocyte to neuron: do neurotransmitters function in the same way throughout development. Cell. Mol. Neurobiol. 1996, 16(5):533-559.
18. Casanova M.F., Buxhoeveden D., Gomez J. Disruption in the inhibitory architecture of the cell minicolumn: implications for autism. Neuroscientist 2003, 9:496-507.
19. Casida J.E., Quistad G.B. Organophosphate toxicology: safety aspects of nonacetylcholinesterase secondary targets. Chem. Res. Toxicol. 2004, 17(8):983-998.
20. Castagna C., Ball G.F., Balthazart J. Effects of dopamine agonists on appetitive and consummatory male sexual behavior in Japanese quail. Pharmacol. Biochem. Behav. 1997, 58403-58414.
21. Chiavegatto S., Nasello A.G., Bernanrdi M.M. Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system. Life Sci. 1998, 62:1875-1888.
22. Chinn C., Lund A.E., Yim G.K.W. The central actions of lidocaine and a pesticide, chlordimeform. Neuropharmacology 1977, 16(12):867-872.
23. Chou C.P., Lu S.Y., Ueng T.H. Modulation of serum concentrations and hepatic metabolism of 17β-estradiol and testosterone by amitraz in rats. Arch. Toxicol. 2008, 82:729-737.
24. Cifariello A., Pompili A., Gasbarri A. 5-HT (7) receptors in the modulation of cognitive processes. Behav. Brain Res. 2007, 195(1):171-179.
25. Colado M.I., Ormazabal M.J., Alfaro M.J., Martin M.I. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat. J. Pharm. Pharmacol. 1993, 45:220-222.
26. Compton D.M. Behavior strategy learning in rat: effects of lesions of the dorsal striatum or dorsal hippocampus. Behav. Processes 2004, 67(3):335-342.
27. Costa L.G., Murphy S.D. Interaction of the pesticide chlordimeform with adrenergic by amitraz, a formamidine pesticide. Toxicol. Lett. 1987, 28:99-104.
28. Costa L.G., Olibet G., Wu D., Murphy S.D. α2-Adrenoceptor as a target for formamidine pesticides: in vitro and in vivo studies in mice. Toxicol. Appl. Pharmacol. 1988, 93:319-328.
29. Cools R., Roberts A.C., Robbins T.W. Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn. Sci. 2008, 12(1):31-40.
30. Dam K., Garcia S.J., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 1999, 116(1):9-20.
31. Dam K., Seidler F.J., Slotkin T.A. Chlorpyrifos releases norepinephrine from adult and neonatal rat brain synaptosomes. Dev. Brain Res. 1999, 118(1-2):129-133.
32. Di Pino G., Moessner R., Lesch K.P., Lauder J.M., Persico A.M. Roles for serotonin in neurodevelopment: more than just neural transmission. Curr. Neuropharmacol. 2004, 2:403-417.
33. Dunnet S.B., Meldrum A., Muir J.L. Frontal-striatal disconnection disrupts cognitive performance of the frontal-type in the rat. Neuroscience 2005, 135:1055-1065.
34. Fanselow M.S. Contextual fear, gestalt memories, and the hippocampus. Behav. Brain Res. 2000, 110:73-81.
35. Flório J.C., Sakate M., Palemo-Neto J. Effects of amitraz on motor function. Pharmacol. Toxicol. 1993, 73:109-114.
36. Folz S.D., Kakuk T.J., Henke C.L., Rector D.L., Tesar F.B. Clinical evaluation of amitraz as a treatment for canine demodicosis. Vet. Parasitol. 1984, 16(3-4):335-341.
37. Galani R., Weiss I., Cassel J.C., Kelche C. Spatial memory, habituation, and reactions to spatial and nonspatial changes in rats with selective lesions of the hippocampus, the entorhinal cortex or the subiculum. Behav. Brain Res. 1998, 96(1-2):1-12.
38. Glowinski J., Iversen L.L. Regional studies of catecholamines in the rat brain-I. The disposition of [3H]norepinephrine, [3H] dopamine and [3H]DOPA in various regions of the brain. J. Neurochem. 1966, 13:655-669.
39. González-Burgos I., Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog. Brain Res. 2008, 172:603-623.
40. Gupta R.C. Brain regional heterogeneity and toxicological mechanisms of organophosphates and carbamates. Toxicol. Mech. Methods 2004, 14(3):103-143.
41. Harrinson I.R., Kozlik A., McCarthy J.F., Palmer B.H., Wakerley S.B., Watkins T.I., Weighton D.M. 1,3,5-Triazapenta-1,4-dienes: chemical aspects of a new group of pesticides. Pestic. Sci. 1973, 4:901-910.
42. Hastings T.G., Zigmond M.J. Identification of catecholprotein conjugates in neostriatal slices incubated with [3H] dopamine: impact of ascorbic acid and glutathione. J. Neurochem. 1994, 63:1126-1132.
43. Herlenius E., Lagercrantz H. Development of neurotransmitter systems during critical periods. Exp. Neurol. 2004, 190(1):8-21.
44. Hollingworth R.M. Chemistry, biological activity, and uses of formamidine pesticides. Environ. Health Perspect. 1976, 14:57-69.
45. Hsu W.H., Schaffer D.D. Effects of topical application of amitraz on plasma glucose and insulin concentrations in dogs. Am. J. Vet. Res. 1988, 49(1):130-131.
46. Insel T.R., Zohar J., Benkelf A.T.C., Murphy D.L. Serotonin in obsessions, compulsions, and the control of aggressive impulses. Ann. N. Y. Acad. Sci. 1990, 600:574-585.
47. Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol. Behav. 2008, 94:121-135.
48. Kim J.J., Clark R.E., Thompson R.F. Hippocampectomy impairs the memory of recently, but not remotely, acquired trace eyeblink conditioned responses. Behav. Neurosci. 1995, 109(2):195-203.
49. Konkle A.T.M., McCarthy M.M. Developmental time course of estradiol, testosterone, and dihydrotestosterone levels in discrete regions of male and female rat brain. Neuroendocrinology 2011, 152(1):223-235.
50. Lakshmana M., Raju T.R. Endosulfan induces small but significant changes in the levels of noradrenaline, dopamine and serotonin in the developing rat brain and deficits in the operant learning performance. Toxicology 1994, 91(2):139-150.
51. Lapiz M.D., Morilak D.A. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 2006, 137:1039-1049.
52. Leret M.L., Rua C., Garcia-Montojo M., Lecumberri M., González J.C. Influence of metyrapone treatment during pregnancy on the development and maturation of brain monoaminergic systems in the rat. Acta Physiol. 2009, 197(4):333-340.
53. Levitt P., Harvey J.A., Friedman E., Simansky K., Murphy E.H. New evidence for neurotransmitter influences on brain development. Trends Neurosci. 1997, 20(6):269-274.
54. Martineau J., Barthelemy C., Jouve J., Muh J.P., Lelord G. Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effects. Dev. Med. Child Neurol. 1992, 34:593-603.
55. May M. Disturbing behavior: neurotoxic effects in children. Environ. Health Perspect. 2000, 108(6):262-267.
56. Martínez-Larrañaga M.R., Del Pino J., Martínez M.A., Díaz M.J., Anadón A. Developmental exposure to amitraz alters the dopamine system. Society of Toxicology. 48th Annual Meeting 2009.
57. Meltzer H.Y., Maes M. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol. Psychiatry 1995, 38(7):450-457.
58. Müller G.H. Amitraz treatment of demodicosis. J. Am. Anim. Hosp. 1983, 19:435-441.
59. Muneoka K., Kuwagata M., Ogawa T., Shioda S. Sex-specific effects of early neonatal progesterone treatment on dopamine and serotonin metabolism in rat striatum and frontal cortex. Life Sci. 2010, 87(23-26):738-742.
60. Nakamura K., Sekine Y., Ouchi Y., Tsujii M., Yoshikawa E., Futatsubashi M., Tsuchiya K.J., Sugihara G., Iwata Y., Suzuki K., Matsuzaki H., Suda S., Sugiyama T., Takei N., Mori N. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatry 2010, 67(1):59-68.
61. Nicotra A., Schatten G. Propranolol, a beta-adrenergic receptor blocker, affects microfilament organization, but not microtubules, during the first division in sea urchin eggs. Cell Motil. Cytoskeleton 1990, 16(3):182-189.
62. Nicotra A., Senatori O. Some characteristics of mitochondrial monoamine oxidase activity in eggs of carp (Cyprinus carpio) and rainbow trout (Salmo gairdneri). Comp. Biochem. Physiol. C 1989, 92(2):401-404.
63. Olvera-Cortés M.E., Anguiano-Rodríguez P., López-Vázquez M.A., Alfaro J.M. Serotonin/dopamine interaction in learning. Prog. Brain Res. 2008, 172:567-602.
64. Palermo-Neto J., Sácate M., Flório J.C. Developmental and behavioral effects of prenatal amitraz exposure in rats. Neurotoxicol. Teratol. 1994, 16(1):65-70.
65. Palermo-Neto J., Sácate M., Flório J.C. Developmental and behavioral effects of postnatal amitraz exposure in rats. Braz. J. Med. Biol. Res. 1997, 30(8):989-997.
66. Pappas S.S., Tiernan C.T., Behrouz B., Jordan C.L., Breedlove S.M., Goudreau J.L., Lookingland K.J. Neonatal androgen-dependent sex differences in lumbar spinal cord dopamine concentrations and the number of A11 diencephalospinal dopamine neurons. J. Comp. Neurol. 2010, 518(13):2423-2436.
67. Pfister W.R., Chinn C., Noland V., Yim G.K.W. Antipyretic-analgesic actions of the formamidine. Similar pesticide chlordimeform. Pharmacologist 1977, 19:216.
68. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity?. J. Toxicol. Environ. Health Part B: Crit. Rev. 1999, 2(2):161-181.
69. Prado-Alcala R.A., Solana-Figueroa R., Galindo L.E., Medina A.C., Quirarte G.L. Blockade of striatal 5-HT2 receptors produces retrograde amnesia in rats. Life Sci. 2003, 74:481-488.
70. Qiao D., Seidler F.J., Padilla S., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period?. Environ. Health Perspect. 2002, 110(11):1097-1103.
71. Qiao D., Seidler F.J., Tate C.A., Cousins M.M., Slotkin T.A. Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ. Health Perspect. 2003, 111(4):536-544.
72. Raines K.W., Seidler F.J., Slotkin T.A. Alterations in serotonin transporter expression in brain regions of rats exposed neonatally to chlorpyrifos. Brain Res. Dev. Brain Res. 2001, 130(1):65-72.
73. Richardson J.R., Caudle W.M., Wang M., Dean E.D., Pennell K.D., Miller G.W. Developmental exposure to the pesticide dieldrin alters the dopamine system and increases neurotoxicity in an animal model of Parkinson's disease. J. Fed. Am. Soc. Exp. Biol. 2006, 20(10):1695-1697.
74. Ridley R.M., Baker H.F., Harder J.A., Pearson C. Effects of lesions of different parts of the septo-hippocampal system in primates on learning and retention of information acquired before or after surgery. Brain Res. Bull. 1996, 40(1):21-32.
75. Riederer P., Sofic E., Konradi C., Kornhuber J., Beckmann H., Dietl M., Moll G., Herbenstreit G. The role of dopamine in control of neurobiological functions. Basic and Clinical Aspects of Neuroscience. The Role of Brain Dopamine 1989, 1-17. Springer, Berlin. E. Fluckiger, E.E. Muller, M.O. Thorner (Eds.).
76. Robinson P.D., Schutz C.K., Macciardi F., White B.N., Holden J.J. Genetically determined low maternal serum dopamine beat-hydroxylase levels and the etiology of autism spectrum disorders. Am. J. Med. Genet. 2001, 100:30-36.
77. Rolls E.T. Neurophysiology and cognitive functions of the striatum. Rev. Neurol. 1994, 150(8-9):648-660.
78. Seamans J.K., Yang C.R. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog. Neurobiol. 2004, 74:1-58.
79. Shapovalova K.B., Kamkina Y.V. Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors. Neurosci. Behav. Physiol. 2008, 38(1):71-79.
80. Seider T.A., Slotkin T.A. Effects of acute hypoxia on neonatal rat brain: regionally selective, long-term alterations in catecholamine levels and turnover. Brain Res. Bull. 1990, 24:157-161.
81. Slikker W., Schwetz B.A. Childhood obesity: the possible role of maternal smoking and impact on public health. J. Children's Health 2003, 1(1):29-40.
82. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 1999, 107(1):71-80.
83. Slotkin T.A., Tate C.A., Cousins M.M., Seidler F.J. Functional alterations in CNS catecholamine systems in adolescence and adulthood after neonatal chlorpyrifos exposure. Dev. Brain Res. 2002, 133(2):163-173.
84. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 2004, 198(2):132-151.
85. Spyker J.M. Assessing the impact of low level chemicals on development: behavioral and latent effects. Fed. Proc. 1975, 34(9):1835-1844.
86. Stanton M.E., Spear L.P. Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol. Teratol. 1990, 12(3):261-267.
87. Stein D.J., Hollander E., Liebowitz M.R. Neurobiology of impulsivity and the impulse control disorders. J. Neuropsychiatry Clin. Neurosci. 1993, 5(1):9-17.
88. Stewart J., Rajabi H. Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat. Brain Res. 1994, 646(1):157-160.
89. Tilson H.A. Neurotoxicology risk assessment guidelines: developmental neurotoxicology. Neurotoxicology 2000, 21:189-194.
90. Toschke A.M., Koletzko B., Slikker W., Hermann M., Von Kries R. Childhood obesity is associated with maternal smoking in pregnancy. Eur. J. Pediatr. 2002, 161(8):445-448.
91. Volkmar F.R. Pharmacological interventions in autism: theoretical and practical issues. J. Clin. Child Psychol. 2001, 30:80-87.
92. Von Kries R., Toschke A.M., Koletzko B., Slikker W. Maternal smoking during pregnancy and childhood obesity. Am. J. Epidemiol. 2002, 156(10):954-961.
93. Wang C.M., Narahashi T., Fukami J. Mechanism of neuromuscular block by chlordimeform. Pestic. Biochem. Physiol. 1975, 5(2):119-125.
94. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharm. Rev. 1992, 43:553-561.
95. Whitaker-Azmitia P.M., Zhang X., Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology 1994, 11(2):125-132.
96. Williams G.V., Castner S.A. Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 2006, 139:263-276.
97. Winneke G. Cross species extrapolation in neurotoxicology: neurophysiological and neurobehavioral aspects. Neurotoxicology 1992, 13(1):15-25.
98. Wisman L.A., Sahin G., Mainga Y.M., Leanza G., Kirik D. Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory. J. Neurosci. 2008, 28(31):7797-7807.
99. Yanai J., Vatury O., Slotkin T.A. Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann. N. Y. Acad. Sci. 2002, 965:473-478.
100. Yim G.R.W., Holsapple M.P., Pfister W.R., Hollingworth R.M. Prostaglandin synthesis inhibited by formamidine pesticides. Life Sci. 1978, 23:2509-2516.